Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Ultragenyx shares tumble lower after rare disease drug fails PhII trial
Ultragenyx shares tumble lower after rare disease drug fails PhII trial
Ultragenyx shares tumble lower after rare disease drug fails PhII trial
Submitted by
admin
on March 23, 2017 - 9:24am
Source:
Endpoints
News Tags:
Ultragenyx
clinical trials
UX007
Glut1 DS
Headline:
Ultragenyx shares tumble lower after rare disease drug fails PhII trial
Do Not Allow Advertisers to Use My Personal information
